Ensituximab
id:
ensituximab-250-1439902
title:
Ensituximab
text:
Ensituximab (NPC-1C) is a chimeric monoclonal antibody under development for as a candidate for treatment of cancers. The target of the antibody is uncertain and is described as "human colorectal and pancreatic carcinoma-associated antigens", a set of tumor antigens isolated from human cancers. The target might be Mucin 5AC. The antibody was discovered by scientists at Neogenix Oncology using tumor antigens that had been identified years earlier by Ariel Hollinshead; the founder of Neogenix had
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Ensituximab
date created:
date modified:
2023-10-18T14:33:10Z
main entity:
{"identifier":"Q12182591","url":"https://www.wikidata.org/entity/Q12182591"}
image:
fields total:
13
integrity:
14